Piper Sandler analyst Matt O'Brien upgraded Tandem Diabetes Care (NASDAQ: TNDM) from Neutral to Overweight with a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE